RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer

Exclusion Criteria

• •Breast cancer patients whose clinical or pathological stage is T4, N2-3 or M1.
• •Known human immunodeficiency virus infection (HIV) or acquired immunodeficiency syndrome (AIDS) related diseases.
• •Other psychiatric disorders that may interfere with the judgment of the study results, or abnormal laboratory tests; and who, in the judgment of the investigator, are considered unfit to participate in the study.
• •Patients with double breast cancer.
• •Severe/uncontrolled intercurrent diseases/infections.
• •Subjects with allogeneic organ transplants requiring immunosuppressive therapy.
• •Hormone receptors ER and PR are negative (any detectable estrogen and progesterone receptors do not express or express \<1%) and/or HER2 overexpression/amplified by FISH detection.
• •Not suitable for hormone receptor modulators (e.g. tamoxifen) and adjuvant endocrine other drug therapy.